Autopsy report · NCT00460967

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

“In light of the company's current financial position we have indefinately suspended the Rheo-AMD trial.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Suspended: paused, and may or may not restart.
• 325 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 3

Sponsor

OccuLogix

Sponsor type

Industry

Conditions

Age-Related Maculopathy

Interventions

Rheopheresis; Rheopheresis

Participants

325 (planned, not actual)

Sites

39

Countries

Canada, Germany, United States

Trials that died the same way

• BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial
  “Company was sold and clinical trial was suspended then teminated” (65% match in meaning)
• The Dose Finding Study of DAOIB Added to tDCS for AD
  “The trial was suspended due to the budget issue” (62% match in meaning)
• Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
  “Suspended because the lack of patients among the time this clinical trial was running.” (61% match in meaning)
• Department of Defense PTSD Adaptive Platform Trial - Master Protocol
  “The trial has been temporarily suspended due to administrative issues” (60% match in meaning)
• Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
  “Trial has been suspended due to lack of resource and staff” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.